CastleArk Alternatives’s Enovis ENOV Stock Holding History

CastleArk Alternatives’s Portfolio ENOV Stock Details ENOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-68,708	Closed	-$5.43M	–	97
2021 Q3	$5.43M	Buy	+68,708	New	+$5.52M	0.21%	117

Other funds holding ENOV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

CastleArk Alternatives's ENOV Position: Q4 2021 in Review

CastleArk Alternatives sold out of Enovis (ENOV) in Q4 2021, closing a stake of 68,708 shares — an estimated $5.43M sold.

CastleArk Alternatives first reported a position in ENOV in Q3 2021 and held it in 1 quarter. The position peaked at $5.43M in Q3 2021. 314 funds tracked by Wall St. Rank hold ENOV as of Q4 2021.

CastleArk Alternatives reported no remaining Enovis position as of Q4 2021 after selling out during the quarter.
CastleArk Alternatives sold 68,708 Enovis shares in Q4 2021, an estimated $5.43M.
CastleArk Alternatives first reported a position in Enovis in Q3 2021 and held it in 1 quarter.
CastleArk Alternatives's Enovis position peaked at $5.43M in Q3 2021.
314 funds tracked by Wall St. Rank held Enovis as of Q4 2021.

Based on CastleArk Alternatives's 13F filing for Q4 2021, filed 18 Feb 2022.